| INTRODUCTION
Lysosomes are membrane-bound organelles whose main function is the degradation of unwanted biomacromolecules delivered by endocytosis or autophagy. They also participate in various other cellular processes, including microbial killing, antigen presentation, maintenance of cholesterol homeostasis, apoptosis, plasma membrane repair and cell migration (Appelqvist, Waster, Kagedal, & Ollinger, 2013; Honey & Rudensky, 2003; Schiefermeier, Teis, & Huber, 2011; Soldati & Neyrolles, 2012) . Lysosome-mediated catabolism is an adaptive process regulated by nutrient status and cellular signaling. Indeed, it has become evident that lysosomes play important roles in nutrient sensing and signaling pathways that control cell metabolism and growth (Settembre, Fraldi, Medina, & Ballabio, 2013) .
By sensing nutritional status and signaling the appropriate cellular response, mammalian/mechanistic target of rapamycin (mTOR), a serine-threonine kinase that belongs to the phosphoinositide 3-kinase (PI3K)-related kinase family, serves as a master regulator of cell and organismal growth. mTOR associates with various other proteins to form two distinct complexes, mTOR complex 1 (mTORC1) and mTORC2, the former of which includes Raptor, PRAS40, mLST8 and Deptor, and the latter of which contains Rictor, mSIN1, Protor, mLST8 and Deptor . mTORC1 is activated by growth factors such as insulin, and nutrients such as amino acids, and it promotes cell growth by inducing and inhibiting anabolic and catabolic processes, respectively, as well as by driving cell cycle progression (Dibble & Manning, 2013; Shimobayashi & Hall, 2014) . mTORC1 is activated directly by the GTP-bound form of Rheb present on the surface of lysosomes, whereas Rheb is inhibited by its GTPase-activating protein (GAP), which is a heterotrimer of tuberous sclerosis complex 1 (TSC1), TSC2 and TBC1D7. Growth factor stimulation inhibits the TSC growth factors and nutrient availability. Amino acids induce the recruitment of mTORC1 to the lysosomal membrane and its consequent activation, but the molecular mechanism of such activation has remained unclear. We have now examined the role of TMEM55B, a lysosomal protein of unknown molecular function, in this process on the basis of the results of proteomics and immunofluorescence analyses showing that TMEM55B interacts with many proteins that participate in mTORC1 activation including components of the vacuolar-type proton ATPase (V-ATPase) and Ragulator complexes at the lysosomal membrane. The amino acid-induced phosphorylation of the mTORC1 substrates S6K and 4E-BP was attenuated in TMEM55B-depleted cells compared with control cells. Depletion of TMEM55B was also found to evoke lysosomal stress as showed by translocation of the transcription factor TFEB to the nucleus. Furthermore, recruitment of the V1 domain subcomplex of V-ATPase to lipid rafts was abrogated in TMEM55B-depleted cells.
Collectively, our results suggest that TMEM55B contributes to assembly of the VATPase complex in lipid rafts of the lysosomal membrane and to subsequent activation of mTORC1. complex and thereby activates Rheb. Nutrients such as amino acids induce the translocation of mTORC1 to lysosomes, where it encounters Rheb. The translocation of mTORC1 to lysosomes is regulated by the Rag GTPases, which are heterodimers consisting of either RagA or RagB bound to RagC or RagD. Rag GTPases are anchored to lysosomes via the Ragulator complex, which is a pentamer consisting of Lamtor1 (also known as p18 or C11orf59), Lamtor2 (p14), Lamtor3 (MP1 or MAPKSP1), Lamtor4 (HBXIP) and Lamtor5 (C7orf59) and which functions as the guanine nucleotide exchange factor (GEF) for RagA and RagB. RagA and RagB are inhibited by the GATOR1 complex, a trimeric GAP comprising Nprl2, Nprl3 and Depdc5. GATOR1 is negatively regulated by the GATOR2 complex, which consists of Mios, Sec13, Seh1l, Wdr24 and Wdr59 (Bar-Peled & Sabatini, 2014; Powis & De Virgilio, 2016) .
Recent studies have shown that the vacuolar-type proton ATPase (V-ATPase), an ATP-dependent proton pump that controls the internal pH of lysosomes, plays a pivotal role in the amino acid-induced activation of mTORC1 (Zoncu, BarPeled, et al., 2011) . V-ATPase is a large multisubunit complex composed of V1 domain and V0 domain subcomplexes, with the peripheral V1 domain being responsible for ATP hydrolysis and the membrane-integral V0 domain mediating proton translocation (Holliday, 2014) . V-ATPase associates with the Ragulator complex on the lysosomal membrane in an amino acid-sensitive manner. The mechanism by which V-ATPase contributes to the activation of mTORC1 by amino acids has remained unclear, however.
TMEM55B was identified as a lysosomal protein of unknown molecular function, although it was shown to contribute to the regulation of phosphatidylinositol 5-monophosphate abundance in the nucleus (Ungewickell et al., 2005; Zou, Marjanovic, Kisseleva, Wilson, & Majerus, 2007) . We have now explored the physiological function of TMEM55B with the adoption of a proteomics approach to identify proteins that associate with TMEM55B. We found that TMEM55B is associated with many proteins that contribute to the amino acid-sensing pathway including components of the V-ATPase and Ragulator complexes at the lysosomal membrane. Depletion of TMEM55B attenuated amino acid-induced mTORC1 activation and assembly of the V-ATPase complex. Our results suggest that TMEM55B contributes to amino acid-dependent mTORC1 activation by promoting V-ATPase assembly.
| RESULTS

| Identification of TMEM55B-interacting proteins
To explore the physiological role of TMEM55B, we generated Neuro2A cells that express a form of TMEM55B tagged with the 3 × FLAG epitope and then purified TMEM55B-containing protein complexes from these cells by immunoprecipitation with antibodies to (anti-) FLAG. Proteins in the final eluate were fractionated by SDS-polyacrylamide gel electrophoresis (PAGE) into 11 gel slices and digested with trypsin, and the generated peptides were subjected to liquid chromatography and tandem mass spectrometry (LC-MS/MS). V-ATPase components, Ragulator components (Lamtor1 and Lamtor3), the small GTPase RagC, GATOR complex components (Mios, Sec13, Seh1l, Wdr24, Wdr59 and Depdc5), TSC complex components (TSC1 and TSC2) and mTOR were identified as TMEM55B-associated proteins. All TMEM55B-associated proteins related to amino acid-induced mTORC1 activation were subjected to semiquantitative analysis on the basis of the identification frequency (Matsumoto et al., 2009) in the LC-MS/MS analysis (Figure 1a) , showing that many of these proteins form a complex (or complexes) with TMEM55B.
To confirm the interaction of TMEM55B with the V-ATPase and Ragulator complexes, we performed coimmunoprecipitation analysis. Lysates of HEK293T cells expressing FLAG-tagged forms of TMEM55B, Lamp1 (negative control) or Lamtor1 (positive control) were thus subjected to immunoprecipitation with anti-FLAG. The resulting precipitates were then subjected to immunoblot analysis with anti-FLAG, anti-ATP6V0D1, anti-Lamtor1, anti-RagA and anti-RagC. ATP6V0D1 (a component of the V0 domain of the V-ATPase complex), Lamtor1, RagA and RagC were all detected in the FLAG-TMEM55B immunoprecipitates ( Figure 1b) . We also confirmed the association of endogenous ATP6V0D1 and Lamtor1 with endogenous TMEM55B in HEK293T cells by a co-immunoprecipitation assay with anti-TMEM55B (Figure 1c ).
Immunofluorescence analysis of transfected HeLa cells showed that hemagglutinin epitope (HA)-tagged TMEM55B was colocalized with endogenous Lamtor1 (Figure 1d ). Furthermore, gel filtration analysis showed that TMEM55B, Lamtor1, ATP6V0D1 and ATP6V1A (a component of the V1 domain of the V-ATPase complex) co-eluted in the same fractions (Figure 1e ). Together, these results suggested that TMEM55B forms a complex (or complexes) with the VATPase and Ragulator complexes.
| TMEM55B interacts with V-ATPase via its transmembrane domains
In silico analysis with the Simple Modular Architecture Research Tool (Schultz, Milpetz, Bork, & Ponting, 1998) predicted that TMEM55B likely contains two hydrophobic or transmembrane domains. Immunoblot analysis with anti-FLAG indeed showed that FLAG-tagged TMEM55B was present in the membrane fraction but | Genes to Cells Genes to Cells
not in the cytosolic fraction of transfected HEK293T cells ( Figure 2a) . We investigated the nature of the association of FLAG-TMEM55B with cellular membranes by subjecting the transfected cell lysates to alkaline extraction with sodium carbonate. Immunoblot analysis showed that FLAG-TMEM55B was resistant to such extraction, as was the integral membrane protein calnexin, whereas the membrane-attached protein GM130 was extracted into the supernatant, suggesting that TMEM55B is an authentic integral membrane protein.
We also examined the membrane topology of TMEM55B with a proteinase protection assay. A membrane fraction prepared from cells expressing TMEM55B tagged either with FLAG at its NH 2 -terminus ( Figure 2b ) or with the Myc epitope at its COOH-terminus ( Figure 2c ) was thus subjected to protease treatment. As a control, we confirmed that the NH 2 -terminus of calnexin, which faces the luminal side of the endoplasmic reticulum, was protected from proteolytic attack, whereas the COOH-terminus of this protein, which is exposed to the cytosolic side, was cleaved. In contrast, both the NH 2 -and COOH-termini of FLAG-TMEM55B or TMEM55B-Myc were completely processed by treatment with proteinase K (Figure 2b ,c), suggesting that both termini of TMEM55B are exposed to the cytosol.
We next investigated which region of TMEM55B is required for binding to V-ATPase by generating a series of HA-tagged deletion mutants of TMEM55B ( Figure 2d ) and examining their ability to associate with ATP6V0D1 by coimmunoprecipitation analysis in HEK293T cells. Whereas full-length TMEM55B and all three mutants that included the putative transmembrane domains interacted with V-ATPase, the mutant that lacked this region failed to do so (Figure 2e ), suggesting that the transmembrane domains are necessary for the interaction of TMEM55B with V-ATPase. We confirmed that TMEM55B colocalized with the lysosomal marker Lamp1, but not with the Golgi marker GM130 or the early-endosome marker EEA1 (Figure 2f ), suggesting that TMEM55B forms a complex with V-ATPase via its transmembrane domains in the lysosome membrane.
| Depletion of TMEM55B attenuates amino acid-induced mTORC1 activation
Given that our results indicated that TMEM55B interacts with the V-ATPase and Ragulator complexes on lysosomes, we examined whether TMEM55B contributes to mTORC1 activation. Activation of mTORC1 in response to amino acids was attenuated in HeLa cells depleted of TMEM55B by transfection with specific small interfering RNAs (siRNAs), as showed by monitoring of the phosphorylation levels of the mTORC1 substrates S6K and 4E-BP (Figure 3a) . Given that mTORC1 activation results in cell growth (Fingar, Salama, Tsou, Harlow, & Blenis, 2002) , we also examined the effect of TMEM55B depletion on cell size. Flow cytometric analysis showed that depletion of TMEM55B reduced the size of HeLa cells (Figure 3b,c) . We further examined whether TMEM55B is required for the recruitment of mTOR to lysosomes. Immunofluorescence analysis showed that colocalization of the lysosomal marker Lamp2 and mTOR induced by stimulation of HEK293T cells with amino acids was abrogated by depletion of TMEM55B (Figure 3d ), suggesting that TMEM55B is indeed required for full activation of mTORC1 on the lysosomal membrane.
| TMEM55B-deficient mice die during embryogenesis
To examine further the physiological function of TMEM55B, we generated mice deficient in this protein. The Tmem55b gene was disrupted in mouse embryonic stem cells by replacement of exons 2 to 6 with IRES-lacZ and PGK-neopoly(A)-loxP cassettes (Figure 4a ). Adult mice heterozygous F I G U R E 1 Identification of TMEM55B-associated proteins with a proteomics approach. (a) Proteins directly implicated in or potentially related to mTORC1 activation that were identified as TMEM55B-associated proteins by proteomics analysis. The spectral counts of peptides detected by LC-MS/MS analysis of immunoprecipitates prepared from a whole-cell extract (WCE) or membrane fraction (Memb. Fr.) of Neuro2A cells stably expressing FLAG-tagged TMEM55B are shown. The amount of each protein was estimated semiquantitatively on the basis of the identification frequency (IF). (b) HEK293T cells infected with retroviruses for FLAG-tagged forms of TMEM55B, Lamp1 (negative control) or Lamtor1 (positive control) were lysed with a 0.3% CHAPS lysis buffer, and the cell extracts were subjected to immunoprecipitation (IP) with anti-FLAG. The resulting precipitates, as well as a portion of the cell extracts (Input), were subjected to immunoblot (IB) analysis with anti-ATP6V0D1, anti-Lamtor1, anti-RagA, anti-RagC, anti-FLAG and anti-HSP90 (loading control). The arrowheads indicate immunoreactive endogenous precipitated proteins, the single asterisk indicates FLAG-tagged Lamtor1, and the two asterisks indicate the heavy chain of immunoglobulin G (IgG). (c) HEK293T cells were lysed with a 0.5% CHAPS lysis buffer, and the cell extract was subjected to immunoprecipitation with anti-TMEM55B or normal IgG. The resulting precipitates, as well as a portion of the cell extract, were subjected to immunoblot analysis with anti-ATP6V0D1, anti-Lamtor1, anti-TMEM55B and anti-GAPDH (negative control). (d) HeLa cells expressing HA-tagged TMEM55B were fixed and processed for immunofluorescence analysis with anti-HA (red) and anti-Lamtor1 (green). Merged images in which nuclei are stained with Hoechst 33258 (blue) are also shown. Scale bar, 20 μm. (e) HEK293T cells were lysed and subjected to gel filtration chromatography, and the resulting fractions were subjected to immunoblot analysis with anti-TMEM55B, anti-Lamtor1, anti-ATP6V0D1 and anti-ATP6V1A | Genes to Cells Genes to Cells
for the Tmem55b mutant allele were healthy, fertile and phenotypically indistinguishable from wild-type (WT) littermates. The ratio of heterozygous to WT offspring generated from Tmem55b +/− intercrosses was also normal, whereas Tmem55b −/− offspring were not born, indicating that the homozygous mutant mice died during embryogenesis. Microscopic examination of embryos showed that, whereas most Tmem55b −/− embryos appeared normal at embryonic day (E) 8.5 (Figure 4b ), they manifested growth retardation at E9.5 ( Figure 4c ). Given that mice nullizygous for Lamtor1, Lamtor2 or RagA undergo developmental arrest (Efeyan et al., 2014; Nada et al., 2009; Teis et al., 2006 ) with a timing similar to that apparent for Tmem55b −/− embryos, the function of TMEM55B may be related to that of the RagRagulator system on lysosomes. (Figure 5a ). We also examined the amino acid-induced recruitment of mTOR to lysosomes in these cell lines. Immunofluorescence analysis showed that the extent of colocalization of Lamp1 and mTOR induced by stimulation with amino acids was less pronounced in Tmem55b −/− cells than in Tmem55b Whereas Lamp1 and HA-TMEM55B appeared to be constitutively colocalized at lysosomes in the absence or presence of amino acid stimulation (Figure 5d ,e), mTOR was colocalized with HA-TMEM55B only in cells stimulated with amino acids (Figure 5f ,g). The molecular localization of TMEM55B thus appears similar to that of the V-ATPase and Ragulator complexes.
| TMEM55B deficiency attenuates amino acid-induced mTORC1 activation
| Depletion of TMEM55B evokes lysosomal stress
Lysosomal status determines the subcellular localization of TFEB, a master regulator of lysosome biogenesis and function, through an mTORC1-mediated mechanism (Martina, Chen, Gucek, & Puertollano, 2012; Roczniak-Ferguson et al., 2012; Sardiello et al., 2009; Settembre et al., 2011 Settembre et al., , 2012 . TFEB is thus phosphorylated by mTORC1 on lysosomes and is localized to the cytosol under nutrient-rich conditions, with inhibition of this process resulting in translocation of TFEB to the nucleus, where it induces the expression of target genes related to lysosome biogenesis and restoration of lysosomal function. We examined the effect of TMEM55B depletion on the localization of TFEB in HeLa cells that stably express a TFEB-EGFP (enhanced green fluorescent protein) fusion construct. Depletion of TMEM55B elicited the nuclear localization of TFEB-EGFP (Figure 6a,b) , suggesting that loss of TMEM55B evokes lysosomal stress and the consequent translocation of TFEB to the nucleus. We next investigated whether a constitutively active form of the RagA/C heterodimer was able to rescue the defect in mTORC1 signaling apparent in cells depleted of TMEM55B. Whereas expression of the WT RagA/C heterodimer had no apparent effect on the subcellular localization of TFEB-EGFP in TMEM55B-depleted cells, expression of the constitutively active heterodimer attenuated the nuclear translocation of the fusion protein (Figure 6c,d) . These results suggested that TMEM55B is an upstream regulator of Rag GTPases and that signaling downstream of Rag GTPase activation in the pathway leading to mTORC1 activation is intact in cells depleted of TMEM55B.
F I G U R E 2 TMEM55B interacts with V-ATPase via its transmembrane domains. (a) Homogenates of HEK293T cells expressing TMEM55B
tagged at its NH 2 -terminus with the FLAG epitope were subjected to extraction with or without Na 2 CO 3 followed by centrifugation to isolate cytosolic (C) and membrane (M) fractions. Equal amounts of protein from each fraction were subjected to immunoblot analysis with antibodies to FLAG, to GM130 (control for peripheral membrane proteins) and to calnexin (control for integral membrane proteins). (b) Microsomes prepared from HEK293T cells expressing TMEM55B tagged with FLAG at its NH 2 -terminus were incubated in the absence or presence of proteinase K and Triton X-100 and then subjected to immunoblot analysis with antibodies to FLAG and to the NH 2 (N)-or COOH (C)-terminal epitopes of calnexin. (c) Microsomes prepared from HEK293T cells expressing TMEM55B tagged with the Myc epitope at its COOH-terminus were examined as in (b). (d) Schematic representation of full-length (FL) and mutant forms of TMEM55B tagged at the NH 2 -terminus with the HA epitope. The transmembrane (TM) domains of TMEM55B are indicated. (e) HEK293T cells expressing HA-tagged full-length or mutant forms of TMEM55B shown in (d) were lysed with a 0.3% CHAPS lysis buffer, and the cell extracts were subjected to immunoprecipitation with anti-HA. The resulting precipitates, as well as a portion of the cell extracts, were subjected to immunoblot analysis with anti-HA, anti-ATP6V0D1 and anti-HSP90. (f) HeLa cells expressing HA-tagged TMEM55B were fixed and processed for immunofluorescence analysis with anti-HA (red) and either anti-Lamp1, anti-GM130 or anti-EEA1 (green). Lamp1, GM130 and EEA1 were examined as lysosomal, Golgi and early-endosomal markers, respectively. Merged images are also shown. Dashed lines indicate cell outlines. Scale bars, 50 μm | Genes to Cells Genes to Cells HASHIMOTO eT Al.
| TMEM55B recruits the V1 domain of V-ATPase to lipid rafts
Given that Lamtor1 is localized to detergent-resistant membrane (DRM), or lipid rafts, of lysosomes (Nada et al., 2009) , we examined whether the V-ATPase complex is located in such DRM. WT or TMEM55B-deficient cells were lysed and fractionated by ultracentrifugation on a discontinuous sucrose density gradient. The gradient was separated into 10 fractions collected from the top of the tube, with DRM being largely restricted to fraction 2. Complexes containing ATP6V1A, ATP6V0D1, Lamtor1 and TMEM55B were also localized with DRM in control cells. In the case of Tmem55b −/− cells, however, whereas Lamtor1 and ATP6V0D1 were similarly localized with DRM, the abundance of ATP6V1A in the DRM-containing fraction was reduced compared with that apparent for WT cells (Figure 6e ), suggesting that the V1 domain of V-ATPase is not assembled with the V0 domain in DRM of TMEM55B-depleted cells. Collectively, these results suggested that TMEM55B contributes to assembly of the V-ATPase complex in DRM of lysosomes.
| DISCUSSION
mTORC1 is recruited to and thereby activated at the lysosomal membrane in response to amino acid stimulation. Whereas many factors that contribute to amino acid-induced mTORC1 activation have been identified (Gonzalez & Hall, 2017; Saxton & Sabatini, 2017) , the underlying molecular mechanism has remained incompletely understood.
We have now shown that TMEM55B interacts with the VATPase and Ragulator complexes and promotes V-ATPase assembly in lipid raft microdomains of the lysosome membrane (Figure 6f) . The V-ATPase complex is necessary for amino acidinduced activation of mTORC1. It associates with the Ragulator complex, and this interaction is weakened by amino acid stimulation, which in turn increases the GEF activity of the Ragulator complex and the consequent loading of RagA and RagB with GTP. However, the precise mechanism responsible for the regulation of mTORC1 by VATPase in response to amino acid stimulation has remained unclear. The V-ATPase complex is composed of the peripheral ATPase V1 domain and the membrane-integral protontranslocating V0 domain. V-ATPase activity is regulated at the level of reversible complex assembly, although the control of V-ATPase assembly in mammalian cells has not been well understood. The absence of the V1 domain from the complex prevents the V-ATPase-dependent acidification of lysosomes. Whereas the lysosomal proton gradient established by V-ATPase is dispensable for mTORC1 activation by amino acids, inhibition of V-ATPase activity blocks such mTORC1 activation by an unknown mechanism. Although amino acid stimulation was recently shown to induce disassembly of the V-ATPase complex, the detailed mechanism has also remained largely unknown.
Our results now show that loss of TMEM55B attenuates mTORC1 activation induced by amino acid stimulation, suggesting that TMEM55B positively regulates the activation of mTORC1 on lysosomes. Given that expression of constitutively active forms of RagA and RagC restored the cytosolic localization of TFEB in cells depleted of TMEM55B, TMEM55B appears to regulate mTORC1 activation upstream of Rag GTPase activation. The localization of the V1 domain (ATP6V1A) of the V-ATPase complex to the DRM fraction of lysosomes was reduced in TMEM55B-deficient cells compared with control cells, suggesting that the V1 domain is lost from the complex in such cells. Collectively, these results suggest that TMEM55B contributes to the assembly of the V-ATPase complex in lipid rafts of lysosomes.
TFEB is a transcriptional regulator of lysosomal homeostasis and serves as a Mediator of lysosomal stress signaling (Settembre et al., 2013) . TFEB is phosphorylated by mTORC1 and anchored at the lysosome membrane under nutrient-rich conditions, whereas the nonphosphorylated form of TFEB translocates to the nucleus under nutrientlimited conditions or in response to mTORC1 inhibition. The accumulation of TFEB in the nucleus results in activation of the expression of lysosome-related genes such as those encoding V-ATPase components and Lamp1 (Sardiello et al., 2009) . We have now shown that TFEB translocates to the nucleus in TMEM55B-depleted cells, suggesting that lysosomal stress is evoked by a decrease in the abundance of TMEM55B in the lysosomal membrane. Comprehensive analysis of TFEB target genes showed that the TMEM55B gene is one such gene (Palmieri et al., 2011) , suggesting that TMEM55B, mTORC1 and TFEB constitute a negative feedback loop. Given that TMEM55B was shown to contribute to regulation of the metabolism of phosphatidylinositol 5-monophosphate and cholesterol, it might regulate V-ATPase assembly or mTORC1 activation by changing the properties of lipid rafts, which serve as a scaffold for the V-ATPase and Ragulator complexes. It is of note that motifs for the binding of sterol regulatory element-binding protein 2 (SREBP2) are present in the promoter region of the human TMEM55B gene and that depletion of either SREBP1 or SREBP2 reduced the abundance of TMEM55B mRNA in Huh7 cells (Medina et al., 2014) . mTORC1 also contributes to lipid metabolism by promoting lipid biosynthesis through the action of SREBPs (Duvel et al., 2010) . These observations suggest that TMEM55B may be regulated by changes in lipid metabolism triggered by mTORC1 and SREBPs.
During preparation of the present manuscript, Willett et al. (2017) showed that TFEB regulates TMEM55B expression and that TMEM55B regulates lysosomal positioning via a dynein adaptor JIP4, which was also identified as a TMEM55B-associated protein in our LC-MS/MS data (Table S2, 
| EXPERIMENTAL PROCEDURES
| Construction of expression plasmids
A mouse cDNA encoding TMEM55B was generated by the polymerase chain reaction (PCR) with PrimeSTAR HS DNA polymerase (Takara, Shiga, Japan) from cDNA prepared from Neuro2A cells. Mouse cDNAs encoding Lamtor1, RagA, RagC and Lamp1 were generated by PCR with PrimeSTAR HS DNA polymerase from cDNA prepared from testis. The cDNAs encoding full-length or deletion mutants of TMEM55B as well as those encoding RagA, RagC, or the constitutively active mutants RagA(Q66L) and RagC(S75N) were subcloned into pEFBOS-HHg (kindly provided by S. Nagata, Kyoto University). The cDNAs encoding TMEM55B and Lamtor1 were also subcloned into p3 × FLAG-CMV-7.1 (Sigma, St. Louis, MO). A cDNA for TMEM55B tagged with the Myc epitope at the COOH-terminus was generated by PCR and subcloned into the pcDNA3.1 vector. The pEGFP-N1-TFEB plasmid (Roczniak-Ferguson et al., 2012 ; #38119; Addgene, Cambridge, MA) and cDNAs for TMEM55B, Lamtor1 and Lamp1 tagged with the FLAG epitope were subcloned into pMX-puro (kindly provided by T. Kitamura, The University of Tokyo).
| Antibodies
Antibodies to GM130, to EEA1 and to HSP90 were obtained from BD Biosciences (San Jose, CA); those to FLAG (mouse monoclonal M2 and rabbit polyclonal) and to the Myc epitope (9E10) were from Sigma; those to HA (HA.11) were from Covance (Princeton, NJ); those to α-tubulin (TU-01) were from Zymed (South San Francisco, CA); those to GAPDH (1D4) were from Enzo Life Sciences (Farmington, NY); those to TMEM55B were from ProteinTech (Chicago, IL); those to GFP were from Frontier Institute (Ishikari, Japan); those to ATP6V0D1 and to Lamp2 (H4B4) were from Abcam (Cambridge, UK); those to ATP6V1A were from GeneTex (Irvine, CA); those to calnexin (NH 2 -and COOH-terminal epitopes) were from Stressgen (Victoria, British Columbia, Canada); those to mTOR, to RagA, to RagC, to S6K, to phospho-S6K, to non-phospho-4E-BP1, to phospho-4E-BP1, to Lamp1 and to Lamtor1 were from Cell Signaling Technology (Beverly, MA); and those to HA (Y-11) and to Lamp1 (1D4B) as well as normal mouse IgG (SC-2025) were from Santa Cruz Biotechnology (Santa Cruz, CA). Alexa Fluor 488-, Alexa Fluor 546-and Alexa Fluor 633-conjugated goat antibodies to mouse, rabbit or rat IgG were obtained from Molecular Probes (Eugene, OR).
| Cell culture, transfection and retroviral infection
Neuro2A, HEK293T, HeLa and Plat-E cells were cultured under a humidified atmosphere of 5% CO 2 at 37°C in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (Invitrogen). The culture medium for Plat-E cells was also supplemented with blasticidin (10 μg/ml). Cells were transfected with the use of the XtremeGene9 (Roche, Mannheim, Germany) or Lipofectamine 2000 (Invitrogen) reagents. For retroviral infection, Plat-E cells were transiently transfected with pMX-puro-based vectors and then cultured for 48 hr. The retroviruses in the resulting culture supernatants were used to infect Neuro2A cells, and the cells were then subjected to selection with puromycin (1 μg/ml). HEK293T cells were transiently transfected with pCL-Ampho and pMX-puro-based vectors and then cultured for 48 hr. The retroviruses in the resulting culture supernatants were used to infect HeLa or HEK293T cells, and the cells were then subjected to selection with puromycin (2 μg/ml). The culture medium for amino acid deprivation was based on DMEM (#11965, Invitrogen) with the exception that all amino acids were omitted, and it was supplemented with 10% dialyzed 
| Isolation of TMEM55B complexes for proteomics analysis
Neuro2A cells infected with a retrovirus encoding FLAGtagged TMEM55B or with the corresponding empty virus were lysed with a solution containing 20 mmol/L HEPESNaOH (pH 7.4), 150 mmol/L NaCl, 0.5% Triton X-100, 1 mmol/L Na 3 VO 4 , 25 mmol/L NaF, aprotinin (10 μg/ml), leupeptin (10 μg/ml) and 1 mmol/L phenylmethylsulfonyl fluoride (PMSF) for the preparation of a whole-cell extract. For preparation of a membrane fraction, the cells were homogenized in a solution containing 20 mmol/L HEPESNaOH (pH 7.5), 0.25 mol/L sucrose, 1 mmol/L Na 3 VO 4 , 25 mmol/L NaF, aprotinin (10 μg/ml), leupeptin (10 μg/ml), 10 μmol/L MG132 and 1 mmol/L PMSF. The homogenate was centrifuged at 1,000 × g for 5 min at 4°C to remove nuclei and nondisrupted cells, and the resulting supernatant was centrifuged at 100,000 × g for 1 hr at 4°C to isolate a membrane pellet. The pellet was solubilized with a lysis buffer (40 mmol/L HEPES-NaOH [pH 7.5], 150 mmol/L NaCl, 10% glycerol, 0.5% Triton X-100, 1 mmol/L Na 3 VO 4 , 25 mmol/L NaF, aprotinin [10 μg/ml], leupeptin [10 μg/ml], 1 mmol/L PMSF), and the insoluble material was removed by centrifugation at 20,400 × g for 15 min at 4°C. The protein concentration of the resulting supernatant was determined with the Bradford assay (Bio-Rad, Richmond, CA). The solubilized membrane fraction as well as the whole-cell extract were then incubated with rotation for 60 min at 4°C with anti-FLAG (M2)-agarose affinity gel (Sigma). The beads were washed three times with the cell lysis buffer, after which protein complexes were eluted by incubation for several minutes at 4°C with the lysis buffer containing the FLAG peptide (Sigma).
| Identification of TMEM55B-associated proteins by LC-MS/MS analysis
LC-MS/MS analysis was performed as described previously (Matsuzaki, Shirane, Matsumoto, & Nakayama, 2011) .
In brief, affinity-purified protein complexes were concentrated by precipitation with chloroform-methanol, fractionated by SDS-PAGE and stained with silver. The stained gel was sliced into 11 equal pieces per lane, and the proteins therein were subjected to in-gel digestion with trypsin. The resulting peptides were dried, dissolved in a mixture of 0.1% trifluoroacetic acid and 2% acetonitrile, and then applied to a nanoflow LC system (Advanced UHPLC; Michrom BioResources, Auburn, CA) equipped with an L-column (C 18 , 0.15 by 50 mm, particle size of 3 μm; CERI, Tokyo, Japan). The peptides were fractionated with a linear gradient of solvent A (0.1% formic acid in water) and solvent B (100% acetonitrile), with 5%-40% solvent B over 20 min, 40%-95% over 1 min and 95% over 9 min at a flow rate of 300 nl/min. Eluted peptides were sprayed directly into an Orbitrap Velos Pro instrument (Thermo Fisher Scientific). MS and MS/MS spectra were obtained automatically in a data-dependent scan mode with a dynamic exclusion option. All MS/MS spectra were compared with protein sequences in the International Protein Index (European Bioinformatics Institute, Hinxton, UK) mouse version 3.44 with the use of the MASCOT algorithm. Trypsin was selected as the enzyme used, the allowed number of missed cleavages was set at one, and carbamidomethylation of cysteine was selected as a fixed modification. Oxidized methionine and NH 2 -terminal pyroglutaminate were searched as variable modifications. Peptide tolerance was 10 ppm, and tolerance of MS/MS ions was 0.8 Da. Assigned high-scoring peptide sequences (MASCOT score of ≥45) were considered for correct identification. If the MASCOT score was <45, the criteria for match acceptance included the following: (i) peptide sequence length of ≥5, (ii) a MASCOT score for individual peptides of ≥35, (iii) at least three blocks of three successive matches or a block of six successive matches for y or b ions, and (iv) a delta score of ≥12. Identified peptides from independent experiments were integrated and regrouped by International Protein Index accession number. Proteins detected in two experiments with whole-cell extracts or membrane fractions of Neuro2A cells expressing FLAG-tagged TMEM55B, but not with those of cells infected with the corresponding empty virus, were considered TMEM55B-associated proteins. Semiquantitative estimation of protein abundance was based on identification frequency (the number of identified peptides in each experiment normalized by the number of peptides theoretically detectable).
| Immunoprecipitation analysis
Immunoprecipitation analysis was described previously (Hirano et al., 2013 .5], 150 mmol/L NaCl, 2.5 mmol/L MgCl 2 , 0.5% CHAPS, 2 mmol/L EGTA) and were then subjected to SDS-PAGE followed by immunoblot analysis (Li et al., 2004; Yokobori et al., 2009 ). The blot images were scanned with a LAS-4000 instrument (GE Healthcare, Little Chalfont, UK).
| Immunofluorescence staining
Immunofluorescence analysis was described previously (Foster, Fernando, Ishida, Nakayama, & Wimalasena, 2003; Nagahama et al., 2001) . In brief, HEK293T cells were cultured on poly-L-lysine-coated cover glasses in amino acidfree DMEM supplemented with 10% dialyzed fetal bovine serum for 50 min and then incubated with or without amino acids for 10 min. They were then fixed for 10 min at room temperature with 4% paraformaldehyde in phosphate-buffered saline (PBS), exposed for 3 min to PBS containing 0.05% Triton X-100 and then incubated consecutively with primary antibodies and Alexa Fluor-labeled goat secondary antibodies in PBS containing 1% bovine serum albumin. HeLa cells or TMEM55B mutant cells were fixed for 10 min at room temperature with 4% paraformaldehyde in PBS, exposed for 5 min to PBS containing 0.2% Triton X-100 and then incubated consecutively with primary antibodies and Alexa Fluor-labeled goat secondary antibodies in PBS containing 1% bovine serum albumin. In some experiments, cells were also stained with Hoechst 33258 (Wako, Tokyo, Japan). All cells were covered with a drop of GEL/MOUNT (Biomeda, Hayward, CA) and were examined with an LSM700 laserscanning confocal microscope (Carl Zeiss, Oberkochen, Germany) equipped with a Plan-Apochromat ×20 objective (numerical aperture [NA] 0.8), a Plan-Neofluar ×40 objective (NA 0.75), a C-Apochromat ×40 objective (NA 1.20, water) or a Plan-Apochromat ×60 objective (NA 1.4, oil). Images were processed with Zen Software (Carl Zeiss) and Adobe Photoshop (Adobe Systems, San Jose, CA). The Pearson's correlation coefficient was measured using ImageJ plug-in, Coloc 2.
| RNA interference
Stealth siRNAs designed for human TMEM55B (#1, 5′-AAT CTCTCATCAACGTGGAAGGCAA-3′; #2, 5′-CGTAAGA GATGTATCTGCTGCTTCT-3′; and #3, 5′-CAAGATGCA TCAGCATGTAGTCAAA-3′) or negative control duplexes (Invitrogen) were introduced into HeLa or HEK293T cells by transfection with Lipofectamine RNAiMax (Invitrogen).
| Cell size analysis
HeLa cells were transferred to conical tubes, washed with PBS, resuspended in 0.5 ml of PBS and stained with propidium iodide for gating of live cells. The mean forward scatter-height (FSC-H) of 3,000 cells was determined by gating on propidium iodide fluorescence with the use of a FACSCalibur flow cytometer and CellQuest pro software (BD Biosciences).
| Generation of TMEM55B mutant mice
Animals were handled in accordance with the guidelines of Kyushu University. Tmem55b tm1(KOMP)Wtsi embryonic stem cells were obtained from the Knockout Mouse Project Repository (UC Davis, Davis, CA) and microinjected into C57BL/6 mouse blastocysts, and the resulting male chimeras were mated with female C57BL/6 mice. Germline transmission of the mutant allele was confirmed by Southern blot analysis. Heterozygous mutant offspring were intercrossed to produce homozygous mutant animals. For genotyping, DNA was extracted from the embryos and analyzed by PCR with the primers 5′-CTTCTATGAAAGGTTGGGCTTC-3′, 5′-CTATGGCTGTTCTTCTTTTTCCAT-3′ and 5′-AAGCT AGGCCAATACTTTTACCAG-3′.
| Generation of TMEM55B mutant cell lines
Tmem55b +/+ and Tmem55b −/− cell lines were established by introduction of the early region of SV40 into primary cultures of embryonic cells prepared from a litter of embryos obtained from an intercross of heterozygous mice.
| Sodium carbonate extraction and protease protection assay
Sodium carbonate extraction and the protease protection assay were described previously (Hashimoto et al., 2014) . NaF, aprotinin [10 μg/ml], leupeptin [10 μg/ml], 10 μmol/L MG132, 1 mmol/L PMSF). The homogenates were centrifuged at 100,000 × g for 1 hr at 4°C, and the resulting pellets were resuspended in a lysis buffer (40 mmol/L HEPESNaOH [pH 7.5], 150 mmol/L NaCl, 10% glycerol, 0.5% Triton X-100, 1 mmol/L Na 3 VO 4 , 25 mmol/L NaF, aprotinin [10 μg/ml], leupeptin [10 μg/ml], 1 mmol/L PMSF). For the protease protection assay, HEK293T cells expressing FLAG-TMEM55B or TMEM55B-Myc were cultured for 1 day, washed with PBS and homogenized in a solution containing 20 mmol/L HEPES-NaOH (pH 7.5), 0.25 mol/L sucrose, 1 mmol/L Na 3 VO 4 , 25 mmol/L NaF, aprotinin (10 μg/ml), leupeptin (10 μg/ml), 10 μmol/L MG132, 1 mmol/L PMSF. The homogenates were centrifuged at 500 × g for 5 min at 4°C to remove debris, and the resulting supernatants were centrifuged at 100,000 × g for 1 hr at 4°C. The new pellets were suspended in homogenization buffer and incubated for 20 min on ice with proteinase K (40 μg/ml; Roche) in the absence or presence of 1% Triton X-100. Proteolysis was terminated by the addition of PMSF to a final concentration of 1 mmol/L.
| Gel filtration chromatography
Gel filtration chromatography was performed with an ÄKTAexplorer 10S system (GE Healthcare) fitted with a Superose 6 10/300 GL column (GE Healthcare). Cells were lysed by incubation for 10 min at 4°C in a solution containing 40 mmol/L HEPES-NaOH (pH 7.5), 120 mmol/L NaCl, 1 mmol/L EDTA, 0.3% CHAPS, 1 mmol/L Na 3 VO 4 , 25 mmol/L NaF, aprotinin (10 μg/ml), leupeptin (10 μg/ ml) and 1 mmol/L PMSF. The lysates were centrifuged at 20,400 × g for 10 min at 4°C, and equal amounts of protein from the resulting supernatants were injected into the column after its equilibration with running buffer (40 mmol/L HEPES-NaOH [pH 7.5], 120 mmol/L NaCl, 1 mmol/L EDTA, 0.3% CHAPS). Elution was performed at a flow rate of 0.4 ml/min, and fractions of 0.48 ml were collected.
| DRM fractionation
Detergent-resistant membrane fractionation was described previously (Nada et al., 2009; Zhang et al., 2014) . In brief, cells were collected with trypsin, washed with PBS and lysed in 2 ml of buffer A (50 mmol/L Tris-HCl [pH 7.4], 50 mmol/L NaCl, 1 mmol/L EDTA, 0.25% Triton X-100, 5 mmol/L 2-mercaptoethanol, 1 mmol/L Na 3 VO 4 , 25 mmol/L NaF, aprotinin [10 μg/ml], leupeptin [10 μg/ml], 1 mmol/L PMSF) with rotation for 75 min at 4°C. The lysates were then subjected to ultracentrifugation at 100,000 × g for 16 hr at 4°C on a discontinuous sucrose gradient (40%-35%-5%). The gradients were separated into 10 fractions collected from the top.
| Statistical analysis
Quantitative data are presented as means ± SD and were analyzed with Student's t test or Fisher's exact test. An adjusted p value was calculated using Benjamini-Hochberg correction. A p value of <.05 was considered statistically significant.
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